Notable Call Buying Activity in Teva Pharma (TEVA) Continues -Susquehanna
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $34.64 +3.59%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -3.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -3.6%
Join SI Premium – FREE
Susquehanna options strategist Alison Edwards notes continued buying activity Teva Pharma (NYSE: TEVA) , as an opening investor bought 15k Jan 15 Calls, most for $1.10, creating ~750k shares to buy.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Susquehanna Downgrades Greenbrier Companies (GBX) to Neutral
- Trump plans to pursue removal of Fed Governor Lisa Cook after court ruling - CNBC interview
- Meta's Zuckerberg Says Ai Agent Tech Progressing Slower Than Expected - Reuters
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
